NeuBase Therapeutics, Inc. (NBSE)
NASDAQ: NBSE · IEX Real-Time Price · USD
0.440
-0.002 (-0.54%)
At close: Apr 26, 2024, 4:00 PM
0.450
+0.010 (2.25%)
After-hours: Apr 26, 2024, 5:01 PM EDT
NeuBase Therapeutics Analyst Ratings
Total Analysts
n/a
Consensus Rating
n/a
Price Target
n/a
Upside
n/a
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Oct 21, 2022 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $240 → $20 | Buy → Hold | Downgrades | $240 → $20 | +4,449.59% | Oct 18, 2022 |
| Chardan Capital | Chardan Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Oct 17, 2022 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $180 → $140 | Strong Buy | Maintains | $180 → $140 | +31,747.13% | Aug 12, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $300 → $200 | Strong Buy | Maintains | $300 → $200 | +45,395.91% | May 31, 2022 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $360 → $180 | Strong Buy | Maintains | $360 → $180 | +40,846.31% | May 13, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Jun 1, 2021 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Feb 12, 2021 |
| RBC Capital | RBC Capital | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jun 16, 2020 |
| Oppenheimer | Oppenheimer | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Apr 1, 2020 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Apr 1, 2020 |
| Chardan Capital | Chardan Capital | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Mar 6, 2020 |
| Guggenheim | Guggenheim | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Feb 7, 2020 |